What we offer you

Who we work with


  • Vislink plc
  • Synety Group Plc

Life Sciences

  • Cathay International Holdings Ltd
  • CVS Group Plc
  • Cyprotex PLC

Support Services

  • Premier Technical Services Group plc
  • Augean PLC
  • Communisis PLC

Investment Funds

  • Weiss Korea Opportunity Fund
  • Premier Energy and Water Trust Plc - Ord Income
  • Raven Russia Ltd.
See all sectors


June 2, 2015

Oxford Pharmascience Group plc, the specialty pharmaceutical company that redevelops medicines to make them better, safer and easier to take, has announced that it has conditionally raised £20 million via a placing of up to 200,000,000 new Ordinary Shares with both new and existing shareholders (the “Placing”) at a price of 10 pence per share. The new Ordinary Shares will represent up to 16.6% of the Company’s issued ordinary share capital immediately following Admission.


July 3, 2015

Latest report

Best Ideas – 2015, 1H Review

Published on July 3, 2015

Download report